Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

about

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

Item

http://www.wikidata.org/entity/Q47416768

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@en

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@nl

type

Item

label

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@en

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@nl

prefLabel

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@en

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

@nl

P1476

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores

@en

P2093

Chi-Chang Weng

http://www.w3.org/2001/XMLSchema#string

Daniel A Jacome

http://www.w3.org/2001/XMLSchema#string

Kuiying Xu

http://www.w3.org/2001/XMLSchema#string

Michelle Taylor

http://www.w3.org/2001/XMLSchema#string

Robert R Luedtke

http://www.w3.org/2001/XMLSchema#string

Suzy Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Dopamine D3 receptor antagonists as therapeutic agents

Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods

Targeting the dopamine D3 receptor: an overview of drug design strategies.

Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders.

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

P304

9905-9910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JMEDCHEM.7B01248

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristoffer Sahlholm

Sean W Reilly

Robert H Mach

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29125762

http://www.w3.org/2001/XMLSchema#string

P932

5767125

http://www.w3.org/2001/XMLSchema#string